Senior biotech writer Adam Feuerstein is in Madrid to cover the European Society for Medical Oncology (ESMO) Congress, where he will be joined by his colleague Andrew Joseph. The pair will provide updates through the ESMO in 30 newsletter, offering insights from the event.
Feuerstein is also preparing to report on the upcoming Moderna-Merck cancer vaccine data reveal, which is expected in the coming days. The announcement follows his recent travel from Boston to Madrid, where he will be covering the latest developments in oncology.
This coverage is part of Feuerstein's broader work as a senior writer and biotech columnist, where he explores the intersection of drug development, business, and Wall Street. He is also known for co-hosting the biotech podcast The Readout Loud and authoring the newsletter Adam’s Biotech Scorecard.